231 - 232 of 232 Trials
-
Compassionate Use of Dupilumab
Provide Compassionate Use of Dupilumab
-
Expanded Access Protocol for Patients With Eosinophilic Esophagitis
This expanded access program is an open-label, single-arm design where consenting patients may participate up until APT-1011 is commercially available in the relevant regions or the protocol is terminated by the Sponsor.
